Cipla Limited, headquartered in Mumbai, India, is a leading global pharmaceutical company specializing in the development and manufacturing of a wide range of pharmaceutical formulations. The company focuses on innovative drug delivery systems, including intranasal and depot formulations, as well as antiviral compositions and combination therapies. Cipla is committed to producing stable formulations and exploring polymorphs to enhance drug efficacy, thereby addressing diverse healthcare needs across various therapeutic areas.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

179 Patents

#3 in Mumbai

#9 in India

#4,654 in the World

Mumbai, India

Cipla Limited

Forward Citations = 498

87 inventors:

Dharmaraj Ramachandra Rao (87 out of 88 patents)

Rajendra Narayanrao Kankan (85 out of 85 patents)

Geena Malhotra (71 out of 79 patents)

4. Amar Lulla (35 out of 38 patents)

5. Srinivas Laxminarayan Pathi (30 out of 30 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cipla Limited. Retrieved from https://idiyas.com/company/cipla

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

8 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

59 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]